newsfilter
← Latest News
PR Newswire·

Elevation Oncology Announces Pricing of $50 Million Public Offering

NEW YORK, June 8, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (NASDAQ:ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of